Schizophrenia as the prototypical psychiatric disorder;Schizophrenie als Leitkrankheit der Psychiatrie

Psychiatrische Praxis

Volumn 39, Issue 4, 2012, Pages 153-156

  Vauth, Roland ^a   Hohagen, Fritz ^b   Lotz Rambaldi, Winfried ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b Psychiatrie ZIP GGmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; MENTAL DISEASE; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; DEINSTITUTIONALIZATION; EVIDENCE-BASED MEDICINE; FORECASTING; GERMANY; HUMANS; MIND-BODY RELATIONS, METAPHYSICAL; NATIONAL HEALTH PROGRAMS; PATIENT ACCEPTANCE OF HEALTH CARE; PSYCHIATRY; PSYCHOTHERAPY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL STIGMA;

EID: 84860603389     PISSN: 03034259     EISSN: 14390876     Source Type: Journal    
DOI: 10.1055/s-0032-1304920     Document Type: Article

References (34)

1. van Os J, Kenis G, Rutten BP. The environment and schizophrenia. Nature: 2010; 468 203 212
2. Vauth R, Cavelti M, Schieting S et al. Recovery bei schizophrenen Störungen: Ergebnis und Prozess im Fokus moderner Behandlung. Schizophrenie Mitteilungen der gfts: 2011; 27 50 57
3. Vauth R. Psychologische Mechanismen bei der Entwicklung von Depression und ihre Implikationen für psychotherapeutische Ansatzpunkte bei schizophrenen Störungen. neuro aktuell (im Druck)
4. Vauth R. Die umfassende Behandlung schizophrener Störungen als klinische Herausforderung. In: Strauß B, Hohagen F, Caspar F. Hrsg. Lehrbuch Psychotherapie. Teilband 1. Göttingen Hogrefe: 2007; 611 646
5. Kumari V, Peters ER, Fannon D et al. Dorsolateral prefrontal cortex activity predicts responsiveness to cognitive-behavioral therapy in schizophrenia. Biol Psychiatry: 2009; 66 594 602
6. Linden DE et al. How psychotherapy changes the brain - the contribution of functional neuroimaging [Review]. Molecular psychiatry: 2006; 11 528 538
7. Dickerson FB, Lehman AF. Evidence-based psychotherapy for schizophrenia: 2011 update. J Nerv Ment Dis: 2011; 199 520 526
8. Garety PA, Bebbington B, Fowler D et al. Implications for neurobiological research of cognitive models of psychosis: a theoretical paper. Psychological Medicine: 2007; 37 1377 1391 (Pubitemid 47581413)
9. Kuipers E, Garety P, Fowler D et al. Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms. Schizophr Bull: 2006; 32 01 24 S31
10. Rathod S, Phiri P, Kingdon D. Cognitive behavioral therapy for schizophrenia. Psychiatr Clin North Am: 2010; 33 527 536
11. Tarrier N. Cognitive behavior therapy for schizophrenia and psychosis: current status and future directions. Clin Schizophr Relat Psychoses: 2010; 4 176 184
12. Lysaker PH, Tunze C, Yanos PT et al. Relationships between stereotyped beliefs about mental illness, discrimination experiences, and distressed mood over 1 year among persons with schizophrenia enrolled in rehabilitation. Soc Psychiatry Psychiatr Epidemiol: 2011; May 21 [Epub ahead of print]
13. Cavelti M, Kvrgic S, Beck EM et al. Self-stigma and its relationship with insight, demoralization, and clinical outcome among people with schizophrenia spectrum disorders. Compr Psychiatry: 2011; Sep 26 [Epub ahead of print]
14. Vauth R, Kleim B, Wirtz M et al. Self-efficacy and empowerment as outcomes of self-stigmatizing and coping in schizophrenia. Psychiatry Research: 2007; 150 71 80 (Pubitemid 46281341)
15. Beck EM, Cavelti M, Kvrgic S et al. Are we addressing the "right stuffo" to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication. Schizophr Res: 2012; 132 42 49
16. Corrigan PW, Rafacz J, Rusch N. Examining a progressive model of self-stigma and its impact on people with serious mental illness. Psychiatry Res: 2001; 189 339 343
17. Hamann J, Mendel R, Cohen R et al. Psychiatrists' use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topics. Psychiatr Serv: 2009; 60 1107 1112
18. Kreyenbuhl J, Nossel IR, Dixon LB. Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: a review of the literature. Schizophrenia Bulletin: 2009; 35 696 703
19. Miklowitz DJ, Otto MW, Frank E et al. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. American Journal of Psychiatry: 2007; 164 1340 1347 (Pubitemid 47461133)
20. Vauth R. Psychotherapie bei schizophrenen Störungen auf der Grundlage modernen Case Managements. In: Falkai P, Pajonc FG. eds. Langzeittherapie der Schizophrenie. Bremen Unimed: 2004; 84 97
21. Dixon LB, Dickerson F, Bellack AS et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull: 2010; 36 48 70
22. Vauth R, Corrigan PW, Clauss M et al. Cognitive strategies versus self-management skills as adjunct to vocational rehabilitation. Schizophr Bull: 2005; 31 55 66 (Pubitemid 41214356)
23. Salize HJ, McCabe R, Bullenkamp J et al. Cost of treatment of schizophrenia in six European countries. Schizophr Res: 2009; 111 70 77
24. Puschner B, Vauth R, Jacobi F et al. Evidence basis of psychotherapy for schizophrenia patients in Germany. Nervenarzt: 2006; 77 1301 1302, 13041309
25. Wobrock T, Pajonk FG, Falkai P. Schizophrenie. Teil 1: Epidemiologie. Ätiopathogenese, Symptomatologie. Fortschr Neurol Psychiat: 2004; 72 98 113
26. Meyer C, Rumpf H-J, Hapke U et al. Lebenszeitprävalenz psychischer Störungen in der erwachsenen Allgemeinbevölkerung. Ergebnisse der TACOS-Studie. Nervenarzt: 2000; 71 535 542 (Pubitemid 30649935)
27. Lotz-Rambaldi W, Hohagen F. Entwicklung der Psychotherapie im Fachgebiet Psychiatrie und Psychotherapie. Erfolgreiche Einbindung. NeuroTransmitter: 2009; 2 (Sonderheft): 6 12
28. Hohagen F. The profile of a psychiatrist. Nervenarzt: 2006; 77 748 750
29. Baxter LR Jr, Schwartz JM, Bergman KS et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry: 1992; 49 681 689
30. Schwartz JM, Stoessel PW, Baxter LR Jr et al. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry: 1996; 53 109 113 (Pubitemid 26049387)
31. Zurowski B, Kordon A, Weber-Fahr W et al. Relevance of orbitofrontal neurochemistry for the outcome of cognitive-behavioural therapy in patients with obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci: 2012; (in press) DOI: 10.1007/s00406-012-0304-0
32. Gesundheitsforschungsrat (GFR) des Bundesministeriums für Bildung und Forschung (BMBF) Roadmap für das Gesundheitsforschungsprogramm der Bundesregierung. 2007
33. Mathers CD, Loncar D. Updated projections of global mortality and burden of disease, 20022030: Data sources, methods and results. Public Library of Science Medicine: 2006; 3 e442
34. Volk der Erschöpften. DER SPIEGEL: 2001; 4 114 122